1
|
Yang Z, Klugah-Brown B, Ding G, Zhou W, Biswal BB. Brain structural differences in cocaine use disorder: Insights from multivariate and neurotransmitter analyses. Prog Neuropsychopharmacol Biol Psychiatry 2024; 136:111159. [PMID: 39366518 DOI: 10.1016/j.pnpbp.2024.111159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Revised: 09/28/2024] [Accepted: 10/01/2024] [Indexed: 10/06/2024]
Abstract
Cocaine use disorder (CUD) is a chronic and relapsing neuropsychiatric disorder characterized by structural and functional brain lesions, posing a significant public health challenge. While the disruptive effects of cocaine on neurotransmitter systems (receptors/transporters) have been well established, the patterns of brain structural abnormalities in CUD and its interaction with other factors remain an ongoing topic of investigation. We employed source-based morphometry (SBM), a multivariate approach on 50 CUD participants and 50 matched healthy controls from the public SUDMEX CONN dataset. This method allowed us to identify co-varying patterns of brain tissue volume differences, and further explore the effect of average cocaine dosage through moderation analysis. Spatial correlation analysis was also performed to examine micro-macro structural consistency between tissue volume variations and chemoarchitectural distribution of dopamine and serotonin. Our SBM analysis findings were consistent with reward-related neuroadaptations in the striato-thalamo-cortical and limbic pathways and also exhibited co-localization with the distribution of dopamine and serotonin systems. The moderation analysis suggested that the average dosage positively strengthens cocaine consumption years' effect on brain structures. By integrating our findings of gray and white matter volume differences and corresponding neurotransmitter profiles, this comprehensive view not only strengthens our understanding of the brain's structural abnormalities in CUD, but also reveals potential mechanisms underlying its development and progression.
Collapse
Affiliation(s)
- Zhenzhen Yang
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, China
| | - Benjamin Klugah-Brown
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, China.
| | - Guobin Ding
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, China
| | - Wenchao Zhou
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, China
| | - Bharat B Biswal
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, China; Department of Biomedical Engineering, New Jersey Institute of Technology, 619 Fenster Hall, Newark, NJ 07102, USA.
| |
Collapse
|
2
|
Luengo N, Goldfield GS, Obregón AM. Association between dopamine genes, adiposity, food addiction, and eating behavior in Chilean adult. Front Nutr 2024; 11:1466384. [PMID: 39385779 PMCID: PMC11463150 DOI: 10.3389/fnut.2024.1466384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 08/22/2024] [Indexed: 10/12/2024] Open
Abstract
Background A frequent consumption of high sugar/fat foods can affect dopamine signaling in the brain and cause sustained stimulation of the reward system. It has been hypothesized that a hypodopaminergic trait results in an individual overeating in order to increase brain DA. Genetic variants in this route have been connected with addiction and eating behaviors. Most studies focus on a specific SNP, and few studies have used multilocus genetic scores, which quantify genetic risk on a continuum. Aim To assess the relationship between multilocus genetic scores based on multiple gene variants in the dopaminergic pathway and measurements of anthropometry, eating behavior, food reinforcement, and food addiction (FA) in Chilean adults. Methods We recruited 221 Chilean adults for a cross-sectional study. A standard anthropometric measurement procedure was followed and eating behavior was examined using the Three Factor Eating questionnaire (TFEQ), Food Reinforcement Value Questionnaire (FRVQ), Yale Food Addiction Scale (YFAS) and 24-h diet recall. Multilocus genetic scores were calculated using TaqMan assays (rs1800497-rs1799732-rs6277-rs4680). Results No differences were found in the entire sample for anthropometric measurements, by MLGS. We found that participants with a score ≥ 2.0 in the MLGS showed higher food choices on the RVFQ and lower energy intake in protein, lipids, SAFA, MUFA, PUFA, dietary cholesterol, omega-3 and Omega-6 fatty acids in the 24-h recall (p < 0.05). Stratified by nutritional condition, the group with obesity had inferior scores on cognitive restriction, greater scores on uncontrolled eating, emotional eating, and responding to palatable food in the RVFQ. Also, in subjects with obesity, there was more food addiction in the group scoring "MLGS ≥2.0 or low dopamine signaling" (53%), compared to the group scored "MLGS <2.0 or high dopamine signaling" (23%) (p-value; 0.05). Emotional Eating scores correlated positively with MLGS in subjects with obesity. Conclusion In adults with obesity, the MLGS of the dopamine pathway, reflecting hypodopaminergic signaling, was associated with greater scores on food addiction and altered eating behavior traits.
Collapse
Affiliation(s)
- Nicole Luengo
- Escuela de Nutrición y Dietética, Facultad de Ciencias para el cuidado de la Salud, Universidad San Sebastián, Concepción, Chile
| | - Gary S. Goldfield
- Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
| | - Ana M. Obregón
- Escuela de Nutrición y Dietética, Facultad de Ciencias para el cuidado de la Salud, Universidad San Sebastián, Concepción, Chile
| |
Collapse
|
3
|
Ricard JA, Labache L, Segal A, Dhamala E, Cocuzza CV, Jones G, Yip SW, Chopra S, Holmes AJ. A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine D 2/3 receptor densities. Commun Biol 2024; 7:1178. [PMID: 39300138 PMCID: PMC11413242 DOI: 10.1038/s42003-024-06836-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Accepted: 09/03/2024] [Indexed: 09/22/2024] Open
Abstract
The biological mechanisms that contribute to cocaine and other substance use disorders involve an array of cortical and subcortical systems. Prior work on the development and maintenance of substance use has largely focused on cortico-striatal circuits, with relatively less attention on alterations within and across large-scale functional brain networks, and associated aspects of the dopamine system. Here, we characterize patterns of functional connectivity in cocaine use disorder and their spatial association with neurotransmitter receptor densities and transporter bindings assessed through PET. Profiles of functional connectivity in cocaine use disorder reliably linked with spatial densities of dopamine D2/3 receptors across independent datasets. These findings demonstrate that the topography of dopamine receptor densities may underlie patterns of functional connectivity in cocaine use disorder, as assessed through fMRI.
Collapse
Affiliation(s)
- Jocelyn A Ricard
- Stanford Neurosciences Interdepartmental Program, Stanford University School of Medicine, Stanford, CA, USA.
| | - Loïc Labache
- Department of Psychiatry, Brain Health Institute, Rutgers University, NJ, USA
| | - Ashlea Segal
- Department of Neuroscience, Yale University, New Haven, CT, USA
- Wu Tsai Institute, Yale University, New Haven, CT, USA
| | - Elvisha Dhamala
- Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA
| | - Carrisa V Cocuzza
- Department of Psychiatry, Brain Health Institute, Rutgers University, NJ, USA
| | - Grant Jones
- Department of Psychology, Harvard University, Cambridge, MA, USA
| | - Sarah W Yip
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - Sidhant Chopra
- Department of Psychiatry, Brain Health Institute, Rutgers University, NJ, USA.
- Orygen, Melbourne, VIC, Australia.
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
| | - Avram J Holmes
- Department of Psychiatry, Brain Health Institute, Rutgers University, NJ, USA.
| |
Collapse
|
4
|
Morys F, Tremblay C, Rahayel S, Hansen JY, Dai A, Misic B, Dagher A. Neural correlates of obesity across the lifespan. Commun Biol 2024; 7:656. [PMID: 38806652 PMCID: PMC11133431 DOI: 10.1038/s42003-024-06361-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 05/20/2024] [Indexed: 05/30/2024] Open
Abstract
Associations between brain and obesity are bidirectional: changes in brain structure and function underpin over-eating, while chronic adiposity leads to brain atrophy. Investigating brain-obesity interactions across the lifespan can help better understand these relationships. This study explores the interaction between obesity and cortical morphometry in children, young adults, adults, and older adults. We also investigate the genetic, neurochemical, and cognitive correlates of the brain-obesity associations. Our findings reveal a pattern of lower cortical thickness in fronto-temporal brain regions associated with obesity across all age cohorts and varying age-dependent patterns in the remaining brain regions. In adults and older adults, obesity correlates with neurochemical changes and expression of inflammatory and mitochondrial genes. In children and older adults, adiposity is associated with modifications in brain regions involved in emotional and attentional processes. Thus, obesity might originate from cognitive changes during early adolescence, leading to neurodegeneration in later life through mitochondrial and inflammatory mechanisms.
Collapse
Affiliation(s)
- Filip Morys
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada.
| | - Christina Tremblay
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada
| | - Shady Rahayel
- Department of Medicine and Medical Specialties, University of Montreal, Montreal, QC, Canada
- Center for Advanced Research in Sleep Medicine, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada
| | - Justine Y Hansen
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada
| | - Alyssa Dai
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada
| | - Bratislav Misic
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada
| | - Alain Dagher
- Montreal Neurological Institute, McGill University, H3A 2B4, Montreal, QC, Canada
| |
Collapse
|
5
|
Anderson NE, Maurer JM, Stephenson D, Harenski K, Caldwell M, Van Rybroek G, Kiehl KA. Striatal brain volume linked to severity of substance use in high-risk incarcerated youth. Dev Psychopathol 2024:1-10. [PMID: 38738358 DOI: 10.1017/s0954579424000804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2024]
Abstract
Substance use disorders among juveniles are a major public health concern and are often intertwined with other psychosocial risk factors including antisocial behavior. Identifying etiological risks and mechanisms promoting substance use disorders remains a high priority for informing more focused interventions in high-risk populations. The present study examined brain gray matter structure in relation to substance use severity among n = 152 high-risk, incarcerated boys (aged 14-20). Substance use severity was positively associated with gray matter volume across several frontal/striatal brain regions including amygdala, pallidum, putamen, insula, and orbitofrontal cortex. Effects were apparent when using voxel-based-morphometric analysis, as well as in whole-brain, data-driven, network-based approaches (source-based morphometry). These findings support the hypothesis that elevated gray matter volume in striatal reward circuits may be an endogenous marker for vulnerability to severe substance use behaviors among youth.
Collapse
Affiliation(s)
| | | | | | | | - Michael Caldwell
- Mendota Mental Health Institute, Madison, WI, USA
- Department of Psychology, University of Wisconsin-Madison, Madison, WI, USA
| | - Greg Van Rybroek
- Mendota Mental Health Institute, Madison, WI, USA
- Department of Psychology, University of Wisconsin-Madison, Madison, WI, USA
| | - Kent A Kiehl
- The Mind Research Network, Albuquerque, NM, USA
- Department of Psychology, University of New Mexico, Albuquerque, NM, USA
| |
Collapse
|
6
|
Betzel R, Puxeddu MG, Seguin C, Bazinet V, Luppi A, Podschun A, Singleton SP, Faskowitz J, Parakkattu V, Misic B, Markett S, Kuceyeski A, Parkes L. Controlling the human connectome with spatially diffuse input signals. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.02.27.581006. [PMID: 38463980 PMCID: PMC10925126 DOI: 10.1101/2024.02.27.581006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/12/2024]
Abstract
The human brain is never at "rest"; its activity is constantly fluctuating over time, transitioning from one brain state-a whole-brain pattern of activity-to another. Network control theory offers a framework for understanding the effort - energy - associated with these transitions. One branch of control theory that is especially useful in this context is "optimal control", in which input signals are used to selectively drive the brain into a target state. Typically, these inputs are introduced independently to the nodes of the network (each input signal is associated with exactly one node). Though convenient, this input strategy ignores the continuity of cerebral cortex - geometrically, each region is connected to its spatial neighbors, allowing control signals, both exogenous and endogenous, to spread from their foci to nearby regions. Additionally, the spatial specificity of brain stimulation techniques is limited, such that the effects of a perturbation are measurable in tissue surrounding the stimulation site. Here, we adapt the network control model so that input signals have a spatial extent that decays exponentially from the input site. We show that this more realistic strategy takes advantage of spatial dependencies in structural connectivity and activity to reduce the energy (effort) associated with brain state transitions. We further leverage these dependencies to explore near-optimal control strategies such that, on a per-transition basis, the number of input signals required for a given control task is reduced, in some cases by two orders of magnitude. This approximation yields network-wide maps of input site density, which we compare to an existing database of functional, metabolic, genetic, and neurochemical maps, finding a close correspondence. Ultimately, not only do we propose a more efficient framework that is also more adherent to well-established brain organizational principles, but we also posit neurobiologically grounded bases for optimal control.
Collapse
Affiliation(s)
- Richard Betzel
- Department of Psychological and Brain Sciences, Indiana University, Bloomington IN 47401
- Cognitive Science Program, Indiana University, Bloomington IN 47401
- Program in Neuroscience, Indiana University, Bloomington IN 47401
| | - Maria Grazia Puxeddu
- Department of Psychological and Brain Sciences, Indiana University, Bloomington IN 47401
| | - Caio Seguin
- Department of Psychological and Brain Sciences, Indiana University, Bloomington IN 47401
| | - Vincent Bazinet
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Andrea Luppi
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | | | | | - Joshua Faskowitz
- Department of Psychological and Brain Sciences, Indiana University, Bloomington IN 47401
| | - Vibin Parakkattu
- Department of Psychological and Brain Sciences, Indiana University, Bloomington IN 47401
- Cognitive Science Program, Indiana University, Bloomington IN 47401
| | - Bratislav Misic
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | | | - Amy Kuceyeski
- Department of Radiology, Weill Cornell Medicine, New York, NY
- Department of Computational Biology, Cornell University, Ithaca, NY
| | - Linden Parkes
- Department of Psychiatry, Brain Health Institute, Rutgers University, Piscataway, NJ, USA
| |
Collapse
|
7
|
Li Z, Li J, Wang N, Lv Y, Zou Q, Wang J. Single-subject cortical morphological brain networks: Phenotypic associations and neurobiological substrates. Neuroimage 2023; 283:120434. [PMID: 37907157 DOI: 10.1016/j.neuroimage.2023.120434] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 10/28/2023] [Accepted: 10/28/2023] [Indexed: 11/02/2023] Open
Abstract
Although single-subject morphological brain networks provide an important way for human connectome studies, their roles and origins are poorly understood. Combining cross-sectional and repeated structural magnetic resonance imaging scans from adults, children and twins with behavioral and cognitive measures and brain-wide transcriptomic, cytoarchitectonic and chemoarchitectonic data, this study examined phenotypic associations and neurobiological substrates of single-subject morphological brain networks. We found that single-subject morphological brain networks explained inter-individual variance and predicted individual outcomes in Motor and Cognition domains, and distinguished individuals from each other. The performance can be further improved by integrating different morphological indices for network construction. Low-moderate heritability was observed for single-subject morphological brain networks with the highest heritability for sulcal depth-derived networks and higher heritability for inter-module connections. Furthermore, differential roles of genetic, cytoarchitectonic and chemoarchitectonic factors were observed for single-subject morphological brain networks. Cortical thickness-derived networks were related to the three factors with contributions from genes enriched in membrane and transport related functions, genes preferentially located in supragranular and granular layers, overall thickness in the molecular layer and thickness of wall in the infragranular layers, and metabotropic glutamate receptor 5 and dopamine transporter; fractal dimension-, gyrification index- and sulcal depth-derived networks were only associated with the chemoarchitectonic factor with contributions from different sets of neurotransmitter receptors. Most results were reproducible across different parcellation schemes and datasets. Altogether, this study demonstrates phenotypic associations and neurobiological substrates of single-subject morphological brain networks, which provide intermediate endophenotypes to link molecular and cellular architecture and behavior and cognition.
Collapse
Affiliation(s)
- Zhen Li
- Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, China
| | - Junle Li
- Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, China
| | - Ningkai Wang
- Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, China
| | - Yating Lv
- Institute of Psychological Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Qihong Zou
- Center for MRI Research, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
| | - Jinhui Wang
- Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, China; Key Laboratory of Brain, Cognition and Education Sciences, Ministry of Education, China; Center for Studies of Psychological Application, South China Normal University, Guangzhou, China; Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University, Guangzhou, China.
| |
Collapse
|
8
|
Zald DH. The influence of dopamine autoreceptors on temperament and addiction risk. Neurosci Biobehav Rev 2023; 155:105456. [PMID: 37926241 PMCID: PMC11330662 DOI: 10.1016/j.neubiorev.2023.105456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 10/22/2023] [Accepted: 10/31/2023] [Indexed: 11/07/2023]
Abstract
As a major regulator of dopamine (DA), DA autoreceptors (DAARs) exert substantial influence over DA-mediated behaviors. This paper reviews the physiological and behavioral impact of DAARs. Individual differences in DAAR functioning influences temperamental traits such as novelty responsivity and impulsivity, both of which are associated with vulnerability to addictive behavior in animal models and a broad array of externalizing behaviors in humans. DAARs additionally impact the response to psychostimulants and other drugs of abuse. Human PET studies of D2-like receptors in the midbrain provide evidence for parallels to the animal literature. These data lead to the proposal that weak DAAR regulation is a risk factor for addiction and externalizing problems. The review highlights the potential to build translational models of the functional role of DAARs in behavior. It also draws attention to key limitations in the current literature that would need to be addressed to further advance a weak DAAR regulation model of addiction and externalizing risk.
Collapse
Affiliation(s)
- David H Zald
- Center for Advanced Human Brain Imaging and Department of Psychiatry, Rutgers University, Piscataway, NJ, USA.
| |
Collapse
|
9
|
Ricard JA, Labache L, Segal A, Dhamala E, Cocuzza CV, Jones G, Yip S, Chopra S, Holmes AJ. A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine D 2/3 receptor densities. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.11.17.567591. [PMID: 38045392 PMCID: PMC10690146 DOI: 10.1101/2023.11.17.567591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Abstract
Background The biological mechanisms that contribute to cocaine and other substance use disorders involve an array of cortical and subcortical systems. Prior work on the development and maintenance of substance use has largely focused on cortico-striatal circuits, with relatively less attention on alterations within and across large-scale functional brain networks, and associated aspects of the dopamine system. The brain-wide pattern of temporal co-activation between distinct brain regions, referred to as the functional connectome, underpins individual differences in behavior. Critically, the functional connectome correlates of substance use and their specificity to dopamine receptor densities relative to other metabotropic receptors classes remains to be established. Methods We comprehensively characterized brain-wide differences in functional connectivity across multiple scales, including individual connections, regions, and networks in participants with cocaine use disorder (CUD; n=69) and healthy matched controls (n=62), Further, we studied the relationship between the observed functional connectivity signatures of CUD and the spatial distribution of a broad range of normative neurotransmitter receptor and transporter bindings as assessed through 18 different normative positron emission tomography (PET) maps. Results Our analyses identified a widespread profile of functional connectivity differences between individuals with CUD and matched healthy comparison participants (8.8% of total edges; 8,185 edges; pFWE=0.025). We largely find lower connectivity preferentially linking default network and subcortical regions, and higher within-network connectivity in the default network in participants with CUD. Furthermore, we find consistent and replicable associations between signatures of CUD and normative spatial density of dopamine D2/3 receptors. Conclusions Our analyses revealed a widespread profile of altered connectivity in individuals with CUD that extends across the functional connectome and implicates multiple circuits. This profile is robustly coupled with normative dopamine D2/3 receptors densities. Underscoring the translational potential of connectomic approaches for the study of in vivo brain functions, CUD-linked aspects of brain function were spatially coupled to disorder relevant neurotransmitter systems.
Collapse
Affiliation(s)
- Jocelyn A. Ricard
- Stanford Neurosciences Interdepartmental Program, Stanford University School of Medicine, Stanford, CA
- Department of Psychology, Yale University, New Haven, CT, USA
| | - Loïc Labache
- Department of Psychology, Yale University, New Haven, CT, USA
| | - Ashlea Segal
- Department of Neuroscience, Wu Tsai Institute, Yale University, New Haven, CT, USA
| | - Elvisha Dhamala
- Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA
| | | | - Grant Jones
- Department of Psychology, Harvard University, Cambridge, MA, USA
| | - Sarah Yip
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - Sidhant Chopra
- Department of Psychology, Yale University, New Haven, CT, USA
| | - Avram J. Holmes
- Department of Psychology, Yale University, New Haven, CT, USA
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- Department of Psychiatry, Brain Health Institute, Rutgers University, Piscataway, NJ, USA
| |
Collapse
|
10
|
Schinz D, Schmitz‐Koep B, Zimmermann J, Brandes E, Tahedl M, Menegaux A, Dukart J, Zimmer C, Wolke D, Daamen M, Boecker H, Bartmann P, Sorg C, Hedderich DM. Indirect evidence for altered dopaminergic neurotransmission in very premature-born adults. Hum Brain Mapp 2023; 44:5125-5138. [PMID: 37608591 PMCID: PMC10502650 DOI: 10.1002/hbm.26451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 06/23/2023] [Accepted: 07/28/2023] [Indexed: 08/24/2023] Open
Abstract
While animal models indicate altered brain dopaminergic neurotransmission after premature birth, corresponding evidence in humans is scarce due to missing molecular imaging studies. To overcome this limitation, we studied dopaminergic neurotransmission changes in human prematurity indirectly by evaluating the spatial co-localization of regional alterations in blood oxygenation fluctuations with the distribution of adult dopaminergic neurotransmission. The study cohort comprised 99 very premature-born (<32 weeks of gestation and/or birth weight below 1500 g) and 107 full-term born young adults, being assessed by resting-state functional MRI (rs-fMRI) and IQ testing. Normative molecular imaging dopamine neurotransmission maps were derived from independent healthy control groups. We computed the co-localization of local (rs-fMRI) activity alterations in premature-born adults with respect to term-born individuals to different measures of dopaminergic neurotransmission. We performed selectivity analyses regarding other neuromodulatory systems and MRI measures. In addition, we tested if the strength of the co-localization is related to perinatal measures and IQ. We found selectively altered co-localization of rs-fMRI activity in the premature-born cohort with dopamine-2/3-receptor availability in premature-born adults. Alterations were specific for the dopaminergic system but not for the used MRI measure. The strength of the co-localization was negatively correlated with IQ. In line with animal studies, our findings support the notion of altered dopaminergic neurotransmission in prematurity which is associated with cognitive performance.
Collapse
Affiliation(s)
- David Schinz
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Benita Schmitz‐Koep
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Juliana Zimmermann
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Elin Brandes
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Marlene Tahedl
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Aurore Menegaux
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Juergen Dukart
- Institute of Neuroscience and MedicineBrain & Behaviour (INM‐7), Research Centre JülichJülichGermany
- Institute of Systems Neuroscience, Medical FacultyHeinrich Heine University DüsseldorfDüsseldorfGermany
| | - Claus Zimmer
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| | - Dieter Wolke
- Department of PsychologyUniversity of WarwickCoventryUK
- Warwick Medical SchoolUniversity of WarwickCoventryUK
| | - Marcel Daamen
- Clinical Functional Imaging Group, Department of Diagnostic and Interventional RadiologyUniversity Hospital BonnBonnGermany
- Department of NeonatologyUniversity Hospital BonnBonnGermany
| | - Henning Boecker
- Clinical Functional Imaging Group, Department of Diagnostic and Interventional RadiologyUniversity Hospital BonnBonnGermany
| | - Peter Bartmann
- Department of NeonatologyUniversity Hospital BonnBonnGermany
| | - Christian Sorg
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
- Department of Psychiatry, School of MedicineTechnical University of MunichMunichGermany
| | - Dennis M. Hedderich
- Department of Neuroradiology, School of MedicineTechnical University of MunichMunichGermany
- TUM‐NIC Neuroimaging Center, School of MedicineTechnical University of MunichMunichGermany
| |
Collapse
|
11
|
Leyton M, Nikolic M. A non-human primate model of cocaine addiction: interpreting associations with increased vs. decreased dopamine function. Neuropsychopharmacology 2023; 48:1419-1421. [PMID: 37438420 PMCID: PMC10425326 DOI: 10.1038/s41386-023-01644-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 06/26/2023] [Indexed: 07/14/2023]
Affiliation(s)
- Marco Leyton
- Department of Psychiatry, McGill University, Montreal, QC, H3A 1A1, Canada.
- Department of Psychology, McGill University, Montreal, QC, H3A 1B1, Canada.
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, H3A 2B4, Canada.
- Integrated Program in Neuroscience, McGill University, Montreal, QC, H3A 1A1, Canada.
- Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, H4B 1R6, Canada.
- Research Unit on Children's Psychosocial Maladjustment, Université de Montréal, Montreal, QC, H3C 3J7, Canada.
| | - Maja Nikolic
- Integrated Program in Neuroscience, McGill University, Montreal, QC, H3A 1A1, Canada
| |
Collapse
|
12
|
Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, Nørgaard M, Beliveau V, Wu Y, Gallezot JD, Aumont É, Servaes S, Scala SG, DuBois JM, Wainstein G, Bezgin G, Funck T, Schmitz TW, Spreng RN, Galovic M, Koepp MJ, Duncan JS, Coles JP, Fryer TD, Aigbirhio FI, McGinnity CJ, Hammers A, Soucy JP, Baillet S, Guimond S, Hietala J, Bedard MA, Leyton M, Kobayashi E, Rosa-Neto P, Ganz M, Knudsen GM, Palomero-Gallagher N, Shine JM, Carson RE, Tuominen L, Dagher A, Misic B. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci 2022; 25:1569-1581. [PMID: 36303070 PMCID: PMC9630096 DOI: 10.1038/s41593-022-01186-3] [Citation(s) in RCA: 164] [Impact Index Per Article: 82.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Accepted: 09/20/2022] [Indexed: 01/13/2023]
Abstract
Neurotransmitter receptors support the propagation of signals in the human brain. How receptor systems are situated within macro-scale neuroanatomy and how they shape emergent function remain poorly understood, and there exists no comprehensive atlas of receptors. Here we collate positron emission tomography data from more than 1,200 healthy individuals to construct a whole-brain three-dimensional normative atlas of 19 receptors and transporters across nine different neurotransmitter systems. We found that receptor profiles align with structural connectivity and mediate function, including neurophysiological oscillatory dynamics and resting-state hemodynamic functional connectivity. Using the Neurosynth cognitive atlas, we uncovered a topographic gradient of overlapping receptor distributions that separates extrinsic and intrinsic psychological processes. Finally, we found both expected and novel associations between receptor distributions and cortical abnormality patterns across 13 disorders. We replicated all findings in an independently collected autoradiography dataset. This work demonstrates how chemoarchitecture shapes brain structure and function, providing a new direction for studying multi-scale brain organization.
Collapse
Affiliation(s)
- Justine Y Hansen
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Golia Shafiei
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Ross D Markello
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Kelly Smart
- Yale PET Center, Yale School of Medicine, New Haven, CT, USA
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Sylvia M L Cox
- Department of Psychiatry, McGill University, Montréal, QC, Canada
| | - Martin Nørgaard
- Department of Psychology, Center for Reproducible Neuroscience, Stanford University, Stanford, CA, USA
- Neurobiology Research Unit, Cimbi & OpenNeuroPET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Vincent Beliveau
- Neurobiology Research Unit, Cimbi & OpenNeuroPET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
- Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
| | - Yanjun Wu
- Yale PET Center, Yale School of Medicine, New Haven, CT, USA
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Jean-Dominique Gallezot
- Yale PET Center, Yale School of Medicine, New Haven, CT, USA
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Étienne Aumont
- Cognitive Pharmacology Research Unit, UQAM, Montréal, QC, Canada
| | - Stijn Servaes
- McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montréal, QC, Canada
| | | | | | | | - Gleb Bezgin
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
- McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montréal, QC, Canada
| | - Thomas Funck
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Taylor W Schmitz
- Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada
| | - R Nathan Spreng
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Marian Galovic
- Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, Zurich, Switzerland
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK
- MRI Unit, Chalfont Centre for Epilepsy, Chalfont Saint Peter, UK
| | - Matthias J Koepp
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK
- MRI Unit, Chalfont Centre for Epilepsy, Chalfont Saint Peter, UK
| | - John S Duncan
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK
- MRI Unit, Chalfont Centre for Epilepsy, Chalfont Saint Peter, UK
| | - Jonathan P Coles
- Department of Medicine, Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
| | - Tim D Fryer
- Department of Clinical Neurosciences, Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
| | - Franklin I Aigbirhio
- Department of Clinical Neurosciences, Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
| | - Colm J McGinnity
- King's College London and Guy's and St. Thomas' PET Centre, Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK
| | - Alexander Hammers
- King's College London and Guy's and St. Thomas' PET Centre, Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK
| | - Jean-Paul Soucy
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Sylvain Baillet
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Synthia Guimond
- Department of Psychiatry, Royal's Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada
- Department of Psychoeducation and Psychology, University of Quebec in Outaouais, Gatineau, QC, Canada
| | - Jarmo Hietala
- Department of Psychiatry, University of Turku and Turku University Hospital, Turku, Finland
| | - Marc-André Bedard
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
- Cognitive Pharmacology Research Unit, UQAM, Montréal, QC, Canada
| | - Marco Leyton
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
- Department of Psychiatry, McGill University, Montréal, QC, Canada
| | - Eliane Kobayashi
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Pedro Rosa-Neto
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
- McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montréal, QC, Canada
| | - Melanie Ganz
- Neurobiology Research Unit, Cimbi & OpenNeuroPET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
| | - Gitte M Knudsen
- Neurobiology Research Unit, Cimbi & OpenNeuroPET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| | - Nicola Palomero-Gallagher
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
- C. and O. Vogt Institute for Brain Research, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
| | - James M Shine
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Richard E Carson
- Yale PET Center, Yale School of Medicine, New Haven, CT, USA
- Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
| | - Lauri Tuominen
- Department of Psychiatry, Royal's Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada
| | - Alain Dagher
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Bratislav Misic
- Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
| |
Collapse
|
13
|
Iqbal M, Cox SML, Jaworska N, Tippler M, Castellanos-Ryan N, Parent S, Dagher A, Vitaro F, Brendgen MR, Boivin M, Pihl RO, Côté SM, Tremblay RE, Séguin JR, Leyton M. A three-factor model of common early onset psychiatric disorders: temperament, adversity, and dopamine. Neuropsychopharmacology 2022; 47:752-758. [PMID: 34625707 PMCID: PMC8783001 DOI: 10.1038/s41386-021-01187-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 09/08/2021] [Accepted: 09/09/2021] [Indexed: 02/03/2023]
Abstract
Commonly comorbid early onset psychiatric disorders might reflect the varying expression of overlapping risk factors. The mediating processes remain poorly understood, but three factors show some promise: adolescent externalizing traits, early life adversity, and midbrain dopamine autoreceptors. To investigate whether these features acquire greater predictive power when combined, a longitudinal study was conducted in youth who have been followed since birth. Cohort members were invited to participate based on externalizing scores between 11 to 16 years of age. At age 18 (age 18.5 ± 0.6 y.o.), 52 entry criteria meeting volunteers had a 90-min positron emission tomography scan with [18F]fallypride, completed the Childhood Trauma Questionnaire, and were assessed with the Structured Clinical Interview for DSM-5. The three-factor model identified those with a lifetime history of DSM-5 disorders with an overall accuracy of 90.4% (p = 2.4 × 10-5) and explained 91.5% of the area under the receiver operating characteristic curve [95% CI: .824, 1.000]. Targeting externalizing disorders specifically did not yield a more powerful model than targeting all disorders (p = 0.54). The model remained significant when including data from participants who developed their first disorders during a three-year follow-up period (p = 3.5 × 10-5). Together, these results raise the possibility that a combination of temperamental traits, childhood adversity, and poorly regulated dopamine transmission increases risk for diverse, commonly comorbid, early onset psychiatric problems, predicting this susceptibility prospectively.
Collapse
Affiliation(s)
- Maisha Iqbal
- grid.416102.00000 0004 0646 3639Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC Canada
| | | | - Natalia Jaworska
- grid.28046.380000 0001 2182 2255Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON Canada ,grid.28046.380000 0001 2182 2255University of Ottawa Institute of Mental Health Research, Ottawa, ON Canada
| | - Maria Tippler
- grid.416102.00000 0004 0646 3639Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC Canada
| | - Natalie Castellanos-Ryan
- grid.14848.310000 0001 2292 3357School of Psychoeducation, Université de Montréal, Montreal, QC Canada
| | - Sophie Parent
- grid.14848.310000 0001 2292 3357School of Psychoeducation, Université de Montréal, Montreal, QC Canada
| | - Alain Dagher
- grid.416102.00000 0004 0646 3639Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC Canada
| | - Frank Vitaro
- grid.14848.310000 0001 2292 3357School of Psychoeducation, Université de Montréal, Montreal, QC Canada ,grid.411418.90000 0001 2173 6322CHU Ste-Justine Research Center, Montreal, QC Canada
| | - Mara R. Brendgen
- grid.411418.90000 0001 2173 6322CHU Ste-Justine Research Center, Montreal, QC Canada ,grid.38678.320000 0001 2181 0211Department of Psychology, Université de Québec à Montréal, Montreal, QC Canada
| | - Michel Boivin
- grid.23856.3a0000 0004 1936 8390Department of Psychology, Université Laval, Quebec, ON Canada ,grid.77602.340000 0001 1088 3909Institute of Genetic, Neurobiological and Social Foundations of Child Development, Tomsk State University, Siberia, Russia
| | - Robert O. Pihl
- grid.77602.340000 0001 1088 3909Institute of Genetic, Neurobiological and Social Foundations of Child Development, Tomsk State University, Siberia, Russia
| | - Sylvana M. Côté
- grid.411418.90000 0001 2173 6322CHU Ste-Justine Research Center, Montreal, QC Canada ,grid.14848.310000 0001 2292 3357Department of Social & Preventative Medicine, Université de Montréal, Montreal, QC Canada
| | - Richard E. Tremblay
- grid.411418.90000 0001 2173 6322CHU Ste-Justine Research Center, Montreal, QC Canada ,grid.14848.310000 0001 2292 3357Departments of Pediatrics & Psychology, Université de Montréal, Montreal, QC Canada ,grid.7886.10000 0001 0768 2743School of Public Health and Sports Science, University College Dublin, Dublin, Ireland ,grid.7429.80000000121866389INSERM, U669 Paris, France
| | - Jean R. Séguin
- grid.411418.90000 0001 2173 6322CHU Ste-Justine Research Center, Montreal, QC Canada ,grid.14848.310000 0001 2292 3357Department of Psychiatry and Addictology, Université de Montréal, Montreal, QC Canada
| | - Marco Leyton
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. .,Department of Psychiatry, McGill University, Montreal, QC, Canada. .,CHU Ste-Justine Research Center, Montreal, QC, Canada. .,Department of Psychology, McGill University, Montreal, QC, Canada. .,Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada.
| |
Collapse
|
14
|
NRM 2021 Abstract Booklet. J Cereb Blood Flow Metab 2021; 41:11-309. [PMID: 34905986 PMCID: PMC8851538 DOI: 10.1177/0271678x211061050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Lam MTY, Duttke SH, Odish MF, Le HD, Hansen EA, Nguyen CT, Trescott S, Kim R, Deota S, Chang MW, Patel A, Hepokoski M, Alotaibi M, Rolfsen M, Perofsky K, Warden AS, Foley J, Ramirez SI, Dan JM, Abbott RK, Crotty S, Crotty Alexander LE, Malhotra A, Panda S, Benner CW, Coufal NG. Profiling Transcription Initiation in Peripheral Leukocytes Reveals Severity-Associated Cis-Regulatory Elements in Critical COVID-19. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2021:2021.08.24.457187. [PMID: 34462742 DOI: 10.1101/2021.10.28.466336] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The contribution of transcription factors (TFs) and gene regulatory programs in the immune response to COVID-19 and their relationship to disease outcome is not fully understood. Analysis of genome-wide changes in transcription at both promoter-proximal and distal cis-regulatory DNA elements, collectively termed the 'active cistrome,' offers an unbiased assessment of TF activity identifying key pathways regulated in homeostasis or disease. Here, we profiled the active cistrome from peripheral leukocytes of critically ill COVID-19 patients to identify major regulatory programs and their dynamics during SARS-CoV-2 associated acute respiratory distress syndrome (ARDS). We identified TF motifs that track the severity of COVID- 19 lung injury, disease resolution, and outcome. We used unbiased clustering to reveal distinct cistrome subsets delineating the regulation of pathways, cell types, and the combinatorial activity of TFs. We found critical roles for regulatory networks driven by stimulus and lineage determining TFs, showing that STAT and E2F/MYB regulatory programs targeting myeloid cells are activated in patients with poor disease outcomes and associated with single nucleotide genetic variants implicated in COVID-19 susceptibility. Integration with single-cell RNA-seq found that STAT and E2F/MYB activation converged in specific neutrophils subset found in patients with severe disease. Collectively we demonstrate that cistrome analysis facilitates insight into disease mechanisms and provides an unbiased approach to evaluate global changes in transcription factor activity and stratify patient disease severity.
Collapse
Affiliation(s)
- Michael Tun Yin Lam
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
- Laboratory of Regulatory Biology, Salk Institute of Biological Studies, La Jolla, CA, USA
| | - Sascha H Duttke
- Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, CA, USA
| | - Mazen F Odish
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Hiep D Le
- Laboratory of Regulatory Biology, Salk Institute of Biological Studies, La Jolla, CA, USA
| | - Emily A Hansen
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- Department of Pediatrics, University of California, San Diego, CA, USA
| | - Celina T Nguyen
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
| | - Samantha Trescott
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- Department of Pediatrics, University of California, San Diego, CA, USA
| | - Roy Kim
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- Department of Pediatrics, University of California, San Diego, CA, USA
| | - Shaunak Deota
- Laboratory of Regulatory Biology, Salk Institute of Biological Studies, La Jolla, CA, USA
| | - Max W Chang
- Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, CA, USA
| | - Arjun Patel
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Mark Hepokoski
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Mona Alotaibi
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Mark Rolfsen
- Internal Medicine Residency Program, Department of Medicine, UC San Diego, CA, USA
| | - Katherine Perofsky
- Department of Pediatrics, University of California, San Diego, CA, USA
- Rady Children's Hospital, San Diego, CA
| | - Anna S Warden
- Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, CA, USA
| | | | - Sydney I Ramirez
- Division of Infectious Diseases, Department of Medicine, University of California, San Diego
- Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA
| | - Jennifer M Dan
- Division of Infectious Diseases, Department of Medicine, University of California, San Diego
- Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA
| | - Robert K Abbott
- Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA
- Consortium for HIV/AIDS Vaccine Development (CHVAD), The Scripps Research Institute, La Jolla, CA, USA
| | - Shane Crotty
- Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA
| | - Laura E Crotty Alexander
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Atul Malhotra
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA USA
| | - Satchidananda Panda
- Laboratory of Regulatory Biology, Salk Institute of Biological Studies, La Jolla, CA, USA
| | - Christopher W Benner
- Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, CA, USA
| | - Nicole G Coufal
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- Department of Pediatrics, University of California, San Diego, CA, USA
- Rady Children's Hospital, San Diego, CA
| |
Collapse
|
16
|
Kroll DS, Feldman DE, Wang SYA, Zhang R, Manza P, Wiers CE, Volkow ND, Wang GJ. The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review. J Neurol Sci 2020; 418:117099. [PMID: 32866814 PMCID: PMC9003866 DOI: 10.1016/j.jns.2020.117099] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2019] [Revised: 07/15/2020] [Accepted: 08/14/2020] [Indexed: 12/30/2022]
Abstract
Adolescence is a period of rapid neural and behavioral development that often precipitates substance use, substance use disorders (SUDs), and other psychopathology. While externalizing disorders have been closely linked to SUD epidemiologically, the comorbidity of internalizing disorders and SUD is less well understood. Neuroimaging studies can be used to measure structural and functional developments in the brain that mediate the relationship between psychopathology and SUD in adolescence. Externalizing disorders and SUD are both associated with structural and functional changes in the basal ganglia and prefrontal cortex in adolescence. The neural mechanisms underlying internalizing disorders and SUD are less clear, but evidence points to involvement of the amygdala and prefrontal cortex. We also highlight independent contributions of SUD, which may vary in certain ways by the substances assessed. A deeper understanding of the neural basis of the relationship between psychopathology and SUD will allow for more informed interventions in this critical developmental stage.
Collapse
Affiliation(s)
- Danielle S Kroll
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Dana E Feldman
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Szu-Yung Ariel Wang
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Rui Zhang
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Peter Manza
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Corinde E Wiers
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA
| | - Nora D Volkow
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA; National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Blvd., Suite 5274, Bethesda, MD 20892-9581, USA
| | - Gene-Jack Wang
- National Institute on Alcohol Abuse and Alcoholism, 10 Center Dr, Rm B2L124, Bethesda, MD 20892-1013, USA.
| |
Collapse
|
17
|
Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders. Neuropharmacology 2020; 183:108402. [PMID: 33189766 DOI: 10.1016/j.neuropharm.2020.108402] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Revised: 10/30/2020] [Accepted: 11/10/2020] [Indexed: 01/11/2023]
Abstract
Impulsivity - the tendency to act without sufficient consideration of potential consequences in pursuit of short-term rewards - is a vulnerability marker for substance use disorders (SUD). Since impulsivity is a multifaceted construct, which encompasses trait-related characteristics and neurocognitive mechanisms, it is important to ascertain which of these aspects are significant contributors to SUD susceptibility. In this review, we discuss how different trait facets, cognitive processes and neuroimaging indices underpinning impulsivity contribute to the vulnerability to SUD. We reviewed studies that applied three different approaches that can shed light on the role of impulsivity as a precursor of substance use related problems (versus a consequence of drug effects): (1) longitudinal studies, (2) endophenotype studies including non-affected relatives of people with SUD, and (3) clinical reference groups-based comparisons, i.e., between substance use and behavioural addictive disorders. We found that, across different methodologies, the traits of non-planning impulsivity and affect-based impulsivity and the cognitive processes involved in reward-related valuation are consistent predictors of SUD vulnerability. These aspects are associated with the structure and function of the medial orbitofrontal-striatal system and hyperexcitability of dopamine receptors in this network. The field still needs more theory-driven, comprehensive studies that simultaneously assess the different aspects of impulsivity in relation to harmonised SUD-related outcomes. Furthermore, future studies should investigate the impact of impulsivity-related vulnerabilities on novel patterns of substance use such as new tobacco and cannabinoid products, and the moderating impact of changes in social norms and lifestyles on the link between impulsivity and SUD. This article is part of the special issue on 'Vulnerabilities to Substance Abuse'.
Collapse
|
18
|
Cox SML, Tippler M, Jaworska N, Smart K, Castellanos-Ryan N, Durand F, Allard D, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté S, Tremblay RE, Séguin JR, Leyton M. mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use. Neuropsychopharmacology 2020; 45:1817-1825. [PMID: 32413893 PMCID: PMC7608187 DOI: 10.1038/s41386-020-0708-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Revised: 05/04/2020] [Accepted: 05/06/2020] [Indexed: 12/14/2022]
Abstract
The excitatory neurotransmitter glutamate has been implicated in experience-dependent neuroplasticity and drug-seeking behaviors. Type 5 metabotropic glutamate (mGlu5) receptors might be particularly important. They are critically involved in synaptic plasticity and their availability has been reported to be lower in people with alcohol, tobacco, and cocaine use disorders. Since these reductions could reflect effects of drug use or pre-existing traits, we used positron emission tomography to measure mGlu5 receptor availability in young adults at elevated risk for addictions. Fifty-nine participants (age 18.5 ± 0.6) were recruited from a longitudinal study that has followed them since birth. Based on externalizing traits that predict future substance use problems, half were at low risk, half were at high risk. Cannabis use histories varied markedly and participants were divided into three subgroups: zero, low, and high use. Compared to low risk volunteers, those at elevated risk had lower [11C]ABP688 binding potential (BPND) values in the striatum, amygdala, insula, and orbitofrontal cortex (OFC). Cannabis use by risk group interactions were observed in the striatum and OFC. In these regions, low [11C]ABP688 BPND values were only seen in the high risk group that used high quantities of cannabis. When these high risk, high cannabis use individuals were compared to all other participants, [11C]ABP688 BPND values were lower in the striatum, OFC, and insula. Together, these results provide evidence that mGlu5 receptor availability is low in youth at elevated risk for addictions, particularly those who frequently use cannabis.
Collapse
Affiliation(s)
- Sylvia M L Cox
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Maria Tippler
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Natalia Jaworska
- Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada
- Institute of Mental Health Research, Affiliated with the University of Ottawa, Ottawa, ON, Canada
| | - Kelly Smart
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Yale PET Center, Yale University, New Haven, CT, USA
| | - Natalie Castellanos-Ryan
- School of Psychoeducation, Université de Montréal, Montreal, QC, Canada
- CHU Ste-Justine Research Center, Montreal, QC, Canada
| | - France Durand
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Dominique Allard
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Chawki Benkelfat
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Sophie Parent
- School of Psychoeducation, Université de Montréal, Montreal, QC, Canada
| | - Alain Dagher
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Frank Vitaro
- School of Psychoeducation, Université de Montréal, Montreal, QC, Canada
- CHU Ste-Justine Research Center, Montreal, QC, Canada
| | - Michel Boivin
- Department of Psychology, Université Laval, Quebec, QC, Canada
| | - Robert O Pihl
- Department of Psychology, McGill University, Montreal, QC, Canada
| | - Sylvana Côté
- CHU Ste-Justine Research Center, Montreal, QC, Canada
- Department of Social and Preventative Medicine, Université de Montréal, Montreal, QC, Canada
| | - Richard E Tremblay
- CHU Ste-Justine Research Center, Montreal, QC, Canada
- Department of Pediatrics and Psychology, Université de Montréal, Montreal, QC, Canada
- School of Public Health, University College Dublin, Belfield, Dublin, Ireland
| | - Jean R Séguin
- CHU Ste-Justine Research Center, Montreal, QC, Canada
- Department of Psychiatry and Addictology, Université de Montréal, Montreal, QC, Canada
| | - Marco Leyton
- Department of Psychiatry, McGill University, Montreal, QC, Canada.
- Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
- Department of Psychology, McGill University, Montreal, QC, Canada.
- Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada.
| |
Collapse
|